| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |